The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Integration of trastuzumab (T), with or without pertuzumab (P), into perioperative chemotherapy (CT) of HER-2 positive gastric (GC) and esophagogastric junction cancer (EGJC): First results of the EORTC 1203 INNOVATION study, in collaboration with the Korean Cancer Study Group, and the Dutch Upper GI Cancer group.
 
Anna Dorothea Wagner
Consulting or Advisory Role - Alligator Bioscience; BMS (Inst); Dragonfly Therapeutics; Lilly; Merck KGaA; MSD Oncology; Pierre Fabre; Servier/Pfizer
Speakers' Bureau - SERVIER
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Abbvie (Inst); Ipsen (Inst); Merck (Inst); MSD Oncology (Inst)
 
Heike I. Grabsch
Honoraria - MSD NL
 
Murielle Mauer
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Roche (Inst)
 
Uberto Fumagalli Romario
Employment - Società Ossigeno Liquido - Vivisol (I)
Leadership - Società Ossigeno Liquido - Vivisol (I)
Stock and Other Ownership Interests - Società Ossigeno Liquido - Vivisol
 
Yoon-Koo Kang
Consulting or Advisory Role - ALX Oncology; Amgen; Blueprint Medicines; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Macrogenics; Novartis; Surface Oncology; Zymeworks
 
Olivier Bouche
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Bayer; Merck Serono; Pierre Fabre; Sanofi; Servier
 
Sylvie Lorenzen
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Pierre Fabre; Roche/Genentech; Sanofi; Servier
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; BMS; Lilly; Merck Serono; MSD; Pfizer; Roche; SERVIER; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; BeiGene; ESMO; German Cancer Society; Merck Serono; MSD; Roche
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Meyers-Squibb; Daiichi Sankyo; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Merck/Pfizer (Inst)
 
Anneli Elme
No Relationships to Disclose
 
Gunnar Folprecht
Honoraria - Bristol-Myers Squibb; Falk Foundation; Merck KGaA; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exact Sciences; Incyte; Merck KGaA; Merck Sharp & Dohme; Pierre Fabre; Roche/Genentech; SERVIER
Research Funding - Merck KGaA
 
Uwe Marc Martens
Travel, Accommodations, Expenses - Ipsen
 
Denis Michel Smith
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Pierre Fabre
 
Maria del Carmen Galan Guzman
No Relationships to Disclose
 
Michel Pierre Ducreux
Employment - Sandoz (I)
Honoraria - Bayer; Pierre Fabre; Roche/Genentech; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Basilea; Bayer; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; HalioDx; Ipsen; Lilly; Merck Serono; MSD; Novartis; Pierre Fabre; Rafael Pharmaceuticals; Roche; Servier; Sotio; Zymeworks
Speakers' Bureau - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; HalioDx; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER
Research Funding - Keocyt (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Pierre Fabre; Roche; SERVIER
 
Marc Díez Garcia
No Relationships to Disclose
 
Guillaume Piessen
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology; Nestle health science
Travel, Accommodations, Expenses - medtronic
(OPTIONAL) Uncompensated Relationships - Medtronic
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; Eutilex; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical
Speakers' Bureau - Amgen; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; Lilly; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks
 
Maike Collienne
Research Funding - Oncolytics (Inst)
 
Florian Lordick
Honoraria - Art Tempi; AstraZeneca; BioNTech; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Elsevier; Falk Foundation; Incyte; Lilly; Medscape; Medupdate; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER; Streamedup!
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Daichi Sankyo; Merck Sharp & Dohme; Novartis; Zymeworks
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly